Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | MIF | P14174 | 2/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.40 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.40 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 2/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL464725 | 0.78 | HCAR2 (0.45) | HCAR2MIFTAAR1LMNAADRA2A | |
| SCHEMBL198133 | 0.78 | HCAR2 (0.45) | HCAR2MIFTAAR1LMNAADRA2A | |
| Ammonia Solution, Strong SCHEMBL27871924 | 0.76 | HCAR2 (0.44) | HCAR2MIFTAAR1LMNAADRA2A | |
| SCHEMBL12280720 | 0.76 | THRB (0.45) | HCAR2TAAR1LMNAADRA2AADRA2C | |
| SCHEMBL57510 | 0.76 | THRB (0.45) | HCAR2TAAR1LMNAADRA2AADRA2C | |
| Hydrochloric Acid SCHEMBL28273439 | 0.76 | ALDH1A1 (0.44) | HCAR2TAAR1LMNAADRA2AADRA2C | |
| SCHEMBL5442572 | 0.76 | HCAR2 (0.44) | HCAR2MIFTAAR1LMNAADRA2A | |
| SCHEMBL2737141 | 0.76 | THRB (0.45) | HCAR2TAAR1LMNAADRA2AADRA2C | |
| Phosphine SCHEMBL20897413 | 0.76 | CYP2D6 (0.46) | HCAR2TAAR1LMNAADRA2AADRA2C | |
| SCHEMBL2330109 | 0.75 | HCAR2 (0.40) | HCAR2MIFTAAR1LMNAADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170217870-A1 | Highly Robust Efficient Catalyst For Selective Dehydrogenation Of Neat Glycerol To Lactic Acid | UNIVERSITY OF SOUTHERN CALIFORNIA | 2017-08-03 | — | — | US | disclosed |
| US-8450442-B2 | Borosiloxane composition, borosiloxane adhesive, coated and laminated substrates | DOW CORNING CORPORATION (US) | 2013-05-28 | — | — | US | disclosed |
| US-20110021736-A1 | Polyborosiloxane and Method of Preparing Same | DOW CORNING CORPORATION | 2011-01-27 | — | — | US | disclosed |
| US-20100316876-A1 | Borosiloxane Composition, Borosiloxane Adhesive, Coated and Laminated Substrates | DOW CORNING CORPORATION | 2010-12-16 | — | — | US | disclosed |
| EP-2254933-A1 | POLYBOROSILOXANE AND METHOD OF PREPARING SAME | Dow Corning Corporation (US) | 2010-12-01 | — | — | EP | disclosed |
| EP-2254934-A1 | BOROSILOXANE COMPOSITION, BOROSILOXANE ADHESIVE, COATED AND LAMINATED SUBSTRATES | Dow Corning Corporation (US) | 2010-12-01 | — | — | EP | disclosed |
| WO-2009111193-A1 | BOROSILOXANE COMPOSITION, BOROSILOXANE ADHESIVE, COATED AND LAMINATED SUBSTRATES | DOW CORNING CORPORATION (US) | 2009-09-11 | — | — | WO | disclosed |
| WO-2009111191-A1 | POLYBOROSILOXANE AND METHOD OF PREPARING SAME | DOW CORNING CORPORATION (US) | 2009-09-11 | — | — | WO | disclosed |
| US-5852221-A | Optically active β-aminoalkoxyborane complex | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1998-12-22 | — | — | US | disclosed |
| US-5808098-A | REDUCING AGENT FROM AMINOALCOHOL | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1998-09-15 | — | — | US | disclosed |
| US-5786485-A | REACTING OPTICALLY ACTIVE BETA-AMINOALCOHOL WITH BORANE REAGENT TO PRODUCE OPTICALLY ACTIVE BETA-AMINOALKOXYBORANE COMPLEX | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1998-07-28 | — | — | US | disclosed |
| US-5739347-A | REDUCING AGENTS FOR DECARBONYLATION | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1998-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170217870-A1 | Highly Robust Efficient Catalyst For Selective Dehydrogenation Of Neat Glycerol To Lactic Acid | LDHA, LDHB, ADH1C | HCAR2 88/4885MIF 961/4885TAAR1 896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.